We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Veradigm Inc | NASDAQ:MDRX | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 6.81 | 6.85 | 6.90 | 0 | 01:00:00 |
Allscripts Healthcare Solutions Inc. said third-quarter revenue rose 11% but missed expectations, and the health-care information-technology company also issued disappointing earnings guidance for the final quarter of the year.
Revenue increased to $392.4 million from $354.5 million a year earlier. Analysts polled by Thomson Reuters had projected revenue of $414.9 million.
For the fourth quarter, Allscripts forecast per-share earnings of 14 cents to 16 cents, below analysts' expectations for 17 cents a share.
Allscripts and private-equity firm GI Partners in April completed their acquisition of health-care information-technology company Netsmart Technologies from Genstar Capital. Under the deal, Netsmart was then combined with Allscripts' home-care software business unit.
The Netsmart acquisition contributed $38 million in revenue for the third quarter. Excluding deferred revenue adjustments related to the Netsmart acquisition, Allscripts' revenue rose 14%.
The Chicago company, which provides software and services to hospitals and other health-care providers, also reported that its bookings rose 7% to $291 million in the latest quarter, with a boost from Netsmart.
Over all, Allscripts Healthcare broke even, compared with a year-earlier loss $5.2 million. On a per-share basis, which reflects convertible preferred stock impacts, Allscripts reported a per-share loss of 6 cents, compared with a year-earlier loss of 3 cents.
Excluding stock-based compensation and other items, per-share earnings were 14 cents, below analysts' average estimates of 15 cents.
Write to Tess Stynes at tess.stynes@wsj.com
(END) Dow Jones Newswires
November 03, 2016 17:35 ET (21:35 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
1 Year Veradigm Chart |
1 Month Veradigm Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions